CONTENTS:
- Effect of modified income assistance payment schedules on substance use service access: Evidence from an experimental study. Robinson K., Laing A., Choi J., Richardson L., art. 104293.
- Adoption of methadone take home policy by U.S. state opioid treatment authorities during COVID-19. Roy V., Buonora M., Simon C., Dooling B., Joudrey P., art. 104302.
- Quasi-experimental study on the impact of local smoke-free policies on smoking among Indonesian adults: Evidence from repeated national health surveys. Septiono W., art. 104307.
- Doing more with less: A proposal to advance cigarette packaging regulations in the United States. Shadel W.G., Martino S.C., Setodji C.M., Dunbar M., Jenson D., Wong J.C.S., et al., art. 104308.
- Availability of substance use screening and treatment within HIV clinical sites across seven geographic regions within the IeDEA consortium. Lancaster K.E., Stockton M., Remch M., Wester C.W., Nash D., Brazier E., et al., art. 104309.
- Privacy and confidentiality in Massachusetts' post-overdose outreach programs: Mixed methods analysis of outreach staff surveys and interviews. Beaugard C.A., Formica S.W., Cummins E.R., Bagley S.M., Beletsky L., Green T.C., et al., art. 104310.
- All-cause mortality before and after DAA availability among people living with HIV and HCV: An international comparison between 2010 and 2019. Requena M.-B., Protopopescu C., Stewart A.C., van Santen D.K., Klein M.B., Jarrin I., et al., art. 104311.
- Integration of substance use disorder treatment in traditional mental health facilities: Timeseries and cross-sectional evaluations. Garrison Y.L., Luo Y., Sahker E., art. 104312.
- Reported exposures to derived cannabis products in California before and after the 2018 federal reclassification of hemp. Madan K., Schmidt S., Chami R.F., Ho R., Lewis J.C., Apollonio D.E., art. 104313.
- The Baltic and Nordic responses to the first Taliban poppy ban: Implications for Europe & synthetic opioids today. Caulkins J.P., Tallaksen A., Taylor J., Kilmer B., Reuter P., art. 104314.
- Cannabis reduction among adolescents as spillover from successful tobacco control. Miech R., Heeringa S.G., Molinaro S., Benedetti E., art. 104315.
- Off-premises demand elasticities for pure alcohol in five Latin American countries: The case of Argentina, Chile, Costa Rica, Honduras, and Uruguay. Paraje G., Araya D., Monteiro M., art. 104316.
- Association between high-threshold practices and buprenorphine treatment termination. Lyle V., Harris S., Heidari O., Boulton K., Hulsey E., Saloner B., et al., art. 104318.
- How to improve the surveillance of the Taliban ban's impact on European drug markets. Giommoni L., art. 104320.
- A scoping review of law enforcement drug seizures and overdose mortality in the United States. Cano M., Timmons P., Hooten M., Sweeney K., Oh S., art. 104321.
- Stronger, longer, better opioid antagonists? Nalmefene is NOT a naloxone replacement. Infante A.F., Elmes A.T., Gimbar R.P., Messmer S.E., Neeb C., Jarrett J.B., art. 104323.
- The effectiveness of court-mandated compulsory treatment in promoting abstinence among people with substance use disorders in Iran. Nakhaee N., Karamouzian M., Sharifi H., Malekshahi K., Moaddeb K.A., Vahidzadeh A., et al., art. 104325.
- Stigma as a local process: Stigma associated with opioid dependency in a rural-mixed Indiana county. Railey A.F., Greene A., art. 104327.
- Social influence in the darknet market: The impact of product descriptions on cocaine sales. Andrei F., Veltri G.A., art. 104328.
- There goes the neighborhood? The public safety enhancing effects of a mobile harm reduction intervention. Fixler A.L., Jacobs L.A., Jones D.B., Arnold A., Underwood E.E., art. 104329.
- Stigma and self-stigma among women within the context of the German "zero alcohol during pregnancy" recommendation: A qualitative analysis of online forums and blogs. Binder A., Kilian C., Hanke S., Banabak M., Berkenhoff C., Petersen K.U., et al., art. 104331.